RecruitingObservational

Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer

NCT ID: NCT02107105Sponsor: M.D. Anderson Cancer CenterLast updated: 2026-04-06

Summary

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

Detailed description

PRIMARY OBJECTIVE: I. To assess post-treatment related health state utilities among patients with rectal cancer after treatment at 2 years. SECONDARY OBJECTIVES: I. To longitudinally compare the effects of treatment on quality of life and utilities among patients treated with or without (neo)adjuvant radiation therapy. II. To characterize the impact of treatment on quality of life and utilities among patients with rectal cancer. III. To assess changes in quality of life and utilities among patients treated for rectal cancer over time. OUTLINE: Patients complete quality of life questionnaires over 20-30 minutes at baseline, 6 and 12 months after surgery, and 2, 3, 4, and 5 years after surgery.

Arms & interventions

OtherQuality-of-Life Assessment
Complete quality of life questionnaire
OtherQuestionnaire Administration
Complete quality of life questionnaire

Outcome measures

Primary

Health state utilities
A health state utility is the degree of preference that individuals or society has for a particular health state or condition.
Time frame: At 24 months post-surgery

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No

Inclusion Criteria: * Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment * Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English Exclusion Criteria: * Patient has been treated with pelvic radiation therapy for a diagnosis other than rectal cancer * Patient has a concurrent cancer diagnosis at the time of consent * Patient has recurrent disease

Study locations (1)

M D Anderson Cancer Center

Houston, Texas, 77030

Recruiting

George J. Chang · Contact

713-792-6940

George J. Chang · Principal Investigator